3-(4-fluorophenyl)-1-methyl-N-[3-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl]pyrazole-5-carboxamide
C25H20FN5O — CID 122284280
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-fluorophenyl)-1-methyl-N-[3-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl]pyrazole-5-carboxamide
3-(4-fluorophenyl)-1-methyl-N-[3-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl]pyrazole-5-carboxamide (PubChem CID 122284280) has the molecular formula C25H20FN5O and a molecular weight of 425.47 g/mol. Its IUPAC name is 3-(4-fluorophenyl)-1-methyl-N-[3-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl]pyrazole-5-carboxamide.
Molecular Properties
| Compound Name | 3-(4-fluorophenyl)-1-methyl-N-[3-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl]pyrazole-5-carboxamide |
|---|---|
| PubChem CID | 122284280 |
| Molecular Formula | C25H20FN5O |
| Molecular Weight | 425.47 g/mol |
| Exact Mass | 425.17 |
| IUPAC Name | 3-(4-fluorophenyl)-1-methyl-N-[3-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl]pyrazole-5-carboxamide |
| SMILES | Cc1cccn2cc(-c3cccc(NC(=O)c4cc(-c5ccc(F)cc5)nn4C)c3)nc12 |
| InChI | InChI=1S/C25H20FN5O/c1-16-5-4-12-31-15-22(28-24(16)31)18-6-3-7-20(13-18)27-25(32)23-14-21(29-30(23)2)17-8-10-19(26)11-9-17/h3-15H,1-2H3,(H,27,32) |
| InChIKey | CLLJQQHQZMZPCZ-UHFFFAOYSA-N |
| XLogP | 5.10 |
| TPSA | 64.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 425.47 |
| LogP ≤ 5 | 5.10 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122284280 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.